Anxiety does not always respond to the first medication a doctor tries. For millions of people, standard first-line treatments like SSRIs or benzodiazepines either fall short or come with side effects that make them hard to sustain. That gap has pushed both patients and clinicians to look at a broader range of psychiatric medications, including drugs that were originally developed for entirely different conditions. Mood stabilizers are one of those categories, and they come with a lot of questions attached.
This article breaks down what mood stabilizers actually are, how they work in the brain, where they fit into anxiety treatment, and what the research says so far. Whether you are newly diagnosed or have been managing anxiety for years, understanding the full picture of available options makes every conversation with a prescriber more productive.
What Mood Stabilizers Actually Do in the Brain
The term “mood stabilizer” is more of a clinical category than a precise pharmacological description. These medications are grouped together because they reduce extreme swings in mood, particularly in conditions like bipolar disorder. But their mechanisms vary significantly from drug to drug, which is exactly why their potential applications extend beyond the conditions they were first approved to treat.
Lithium, for example, affects multiple neurotransmitter systems and is thought to modulate glutamate signaling, which plays a role in stress reactivity. Valproate (sold under brand names including Depakote) enhances the activity of GABA, the brain’s primary inhibitory neurotransmitter. Lamotrigine works partly by blocking sodium channels, which stabilizes neuronal firing. Each of these mechanisms touches brain systems that are also involved in anxiety, which is why researchers have explored their use for anxiety-related conditions.
GABA, in particular, is a neurotransmitter that is central to how the brain manages fear and arousal. Medications that boost GABAergic activity tend to have calming effects, which is also why benzodiazepines work the way they do. The key difference is that mood stabilizers like valproate work through a slower, less direct pathway than benzodiazepines, which means they carry a very different risk profile.
The Most Common Mood Stabilizers and Their Primary Uses
| Medication | Common Brand Name(s) | FDA-Approved Primary Use | GABAergic Activity |
| Lithium | Lithobid | Bipolar disorder | Indirect / minimal |
| Valproate / Valproic Acid | Depakote, Depakene | Bipolar disorder, epilepsy, migraine prevention | Strong (increases GABA) |
| Lamotrigine | Lamictal | Bipolar disorder, epilepsy | Moderate |
| Carbamazepine | Tegretol | Bipolar disorder, epilepsy, nerve pain | Moderate |
| Gabapentin | Neurontin | Epilepsy, nerve pain | Strong (GABA analog) |
It is worth noting that gabapentin occupies a somewhat unusual space. Technically an anticonvulsant rather than a classic mood stabilizer, it is often grouped with this category in psychiatric discussions because of its calming properties and frequent off-label use for anxiety. Prescribers sometimes use these medications interchangeably depending on a patient’s specific symptom profile and medical history.
Off-Label Use: When Doctors Prescribe Beyond the Approved Indication
Off-label prescribing is legal, common, and often well-supported by evidence. The FDA approval process evaluates a drug for a specific condition, but once approved, physicians can prescribe it for any condition they believe it may benefit. According to a study published in PLOS ONE, approximately 21 percent of all outpatient prescriptions in the United States are written for off-label purposes, and psychiatric medications are among the most frequently prescribed off-label.
For anxiety specifically, several mood stabilizers have accumulated meaningful clinical evidence even without formal FDA approval for that use. Gabapentin has been studied for social anxiety disorder and generalized anxiety disorder. Valproate has been examined in the context of post-traumatic stress disorder and panic disorder. Lamotrigine has shown some promise in PTSD-related symptom reduction. None of these are considered first-line treatments for anxiety, but they represent legitimate options when standard medications are not enough or are not tolerated.
A psychiatrist evaluating a patient with treatment-resistant anxiety might consider these options alongside a full history of prior medication trials, current diagnoses, and any co-occurring conditions like bipolar disorder, which would change the clinical picture considerably.
Valproate and Anxiety: A Closer Look
Valproate is one of the more studied mood stabilizers in the context of anxiety, largely because of its strong effect on GABA. Patients and caregivers who come across this medication in the context of anxiety treatment often wonder whether Depakote can help with anxiety, especially when they have already tried multiple antidepressants or anti-anxiety medications without adequate relief.
The clinical picture for valproate and anxiety is mixed but not without promise. Some small studies and case reports have found benefit in patients with panic disorder and anxiety symptoms associated with PTSD. A broader concern is the side effect profile. Valproate carries risks that include weight gain, hair thinning, liver enzyme elevation, and, critically, serious risks to fetal development during pregnancy. These factors mean that prescribers weigh valproate carefully and typically reserve it for patients who have not responded to safer first-line options.
People with a dual diagnosis of bipolar disorder and an anxiety disorder are often the clearest candidates. In those cases, treating the bipolar disorder with valproate may simultaneously reduce anxiety symptoms that were being amplified by mood instability, which makes the risk-benefit calculation more straightforward.
Questions Worth Asking Before Starting a Mood Stabilizer
Starting any psychiatric medication is a significant decision. Mood stabilizers often require more monitoring than antidepressants, including blood tests to check drug levels and liver or kidney function. Before beginning treatment, a well-informed patient typically walks into that appointment with specific questions ready.
- Has my anxiety been fully evaluated for any underlying or co-occurring conditions like bipolar disorder or PTSD?
- What first-line treatments have I tried, and why is a mood stabilizer being considered at this point?
- What monitoring will be required, and how often will we check blood levels or organ function?
- What are the most common side effects, and what should I do if I notice them?
- Are there any medications, supplements, or dietary factors that interact with this drug?
- How long does it typically take to see whether this medication is working?
- What does the discontinuation process look like if we decide to stop?
These questions are not just practical, they are a form of informed consent in action. The more a patient understands about why a medication is being chosen, what to expect, and how success will be measured, the more likely treatment is to proceed without surprises.
The Broader Context: Medication Is One Part of Anxiety Treatment
Even when mood stabilizers or other medications are appropriate, they rarely work in isolation for anxiety. Psychotherapy, particularly cognitive behavioral therapy, has one of the strongest evidence bases of any anxiety treatment. A 2018 meta-analysis published in Psychological Medicine found that CBT produced significant reductions in anxiety symptoms across multiple anxiety disorders, with effects that often outlasted medication-only interventions after treatment ended.
Lifestyle factors also carry real weight. Sleep quality, physical activity, alcohol intake, and chronic stress all interact with anxiety symptoms and with how well medications work. A medication that might produce modest benefit in one context can look far more effective when it is part of a comprehensive plan that includes therapy, good sleep habits, and manageable stress levels.
This is not to say medication is secondary or optional for everyone. For some people, medication is what makes everything else possible by lowering the baseline level of distress enough to engage in therapy, sleep consistently, and function at work and in relationships. The ideal approach depends on the individual, and that individualization is exactly what a skilled psychiatrist or psychiatric nurse practitioner is trained to provide.
Finding the Right Fit Takes Time
Psychiatric treatment is rarely a straight line. Many people cycle through several medications before finding one that works well with minimal side effects. That experience can be discouraging, but it reflects the current state of psychiatric medicine rather than a failure on the patient’s part. The brain is complex, individual variation in drug metabolism and receptor sensitivity is real, and clinicians are often working with incomplete information about what will work for a specific person.
Mood stabilizers represent one area of legitimate inquiry for people whose anxiety has not responded to more conventional treatments. Understanding what they are, how they function, and what the evidence supports allows patients to participate meaningfully in treatment decisions rather than simply accepting a prescription without context. That kind of engaged partnership with a prescriber tends to produce better outcomes, not because it changes the pharmacology, but because it changes how people approach their own care.See More